Home Visiting and CHIP Extended For Two Years
Early Childhood advocates across the nation are celebrating news of President Obama signing the SGR bill into law! SGR includes funding to continue MIECHV for the next 2 years and also continues support for CHIP (Children’s Health Insurance Program). In a rare display of bipartisan support, the bill received overwhelming support in both the House (392-37) and the Senate (92-8).
Please give yourself a much deserved pat on the back! And, be sure to thank those who helped make this happen—our local advocates and our legislators who voted to continue this important funding. Both Senator Warner and Senator Kaine voted in support of this legislation and all but one of Virginia’s Congressional Representatives (Dave Brat, Republican, 7th District) voted in favor of this legislation. Please be reach out to your local representative and Senator to thank him or her for their support. And, plan to join us as we continue our work to educate Virginia leaders about the effectiveness of home visiting and the importance of investing in early childhood.
See a brief summary of this legislation HERE.
As always, thanks for all that you do on behalf of Virginia families and children!
Laurel Aparicio, MPA
Director, Virginia Home Visiting Consortium
Since 2006, the Virginia Home Visiting Consortium has been advancing the delivery of high quality, efficient services that improve the health, social, and educational outcomes for new and expecting parents, young children, and their families within safe homes and connected communities.
Core strategies: Guide, Lead, Collaborate, and Research
Prescription painkiller overdoses are an under-recognized and growing problem for women. Heroin and prescription drug use has increased significantly in the past ten years and overdose is now the leading cause of accidental death in the US. Prescription pain medications such as Oxycotin, Percocet, Tylenol #3, and Fentanyl are chemically similar to heroin and affect the body the same way. As individuals seek less costly alternatives to pain medication, many have turned to heroin. These drugs are collectively referred to as opiates and their use can result in overdose.
According to the Center for Disease Control (CDC) ď Deaths from prescription painkiller overdoses among women increased more than 400% during 1999Ė2010, compared to 237% among men.2 The Virginia Maternal Mortality Review Team (MMRT) , which reviews the deaths of all Virginia women who die during or within one year of their pregnancy delivery , found that substance use was a factor in 96 (24 %) of 397 maternal deaths from 1999-2007; of these women 34 (8.6 %) died as a result of an unintended overdose.
Itís not just women who experience consequences, however. Whenever a pregnant woman uses an opiate, both she and her unborn baby may be affected. Whether legal or illegal, prescribed or not, opiates pass through the motherís placenta to her baby. If a pregnant woman uses opiates often enough and in sufficient amounts, both she and her baby will become physically dependent upon them and experience withdrawal if she stops or reduces her use. Itís important to let these moms know that stopping or reducing their use can be harmful to their baby and may cause them to miscarry.
Pregnant women who use opiates should be evaluated and, if appropriate, placed on medially assisted treatment (MAT) for the remainder of their pregnancy. Methadone and Buprenorphine are long acting opiates that can be safely used during pregnancy. When used in conjunction with substance abuse treatment, they reduce the motherís risk of using other drugs and help ensure better outcomes for the baby.
Following delivery, opiate exposed babies may experience symptoms such as loud, high-pitched cries , sweating, yawning and gastrointestinal disturbances. Multiple factors e.g. genetics, health etc determine the severity of the babyís withdrawal; the motherís level of use is only one of them. In its more severe form, the withdrawal syndrome is referred to as Neonatal abstinence syndrome (NAS). Babies with NAS may need to remain hospitalized so that they can be placed on medication and be slowly tapered off of it.
Concerned about Someone?
Learn what services are available at her CSB and how to access them. ( If she needs residential treatment or medically assisted treatment (MAT) the CSB will coordinate a referral).
Screen her for substance use - Ask about her use of prescription and over the counter medications.
Do a Brief Intervention Ė if you have concerns about her use of opiates, educate her regarding their possible effects on her and her unborn baby.
Let her know treatment is available. Refer her to her local CSB for an assessment and services. Provide support , education and encouragement.
Virginia Home Visiting Consortium James Madison University Fax: 540-568-6409 email@example.com
Supported by project D89MC23543 from the U.S. Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau (Title V, Social Security Act, Patient Protection and Affordable Care Act of 2010).